PARIS, France—Darexaban, a novel oral factor Xa inhibitor, was associated with a twofold to fourfold increased risk of major bleeding when added to aspirin and/or clopidogrel in patients with acute ...
SEATTLE--(BUSINESS WIRE)--Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results